Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

Inventiva SA

Start price
Target price
Perf. (%)
€11.54
10.09.21
€8.00
10.09.22
-63.65%
11.09.22

Could be worthwhile Investment >10% per year
buy
Inventiva SA

Start price
Target price
Perf. (%)
€2.18
10.09.21
€12.00
-
10.09.21

Could be worthwhile Investment >10% per year
Inventiva SA

Start price
Target price
Perf. (%)
€2.18
10.09.21
€8.00
-
10.09.21

Could be worthwhile Investment >10% per year
buy
Bone Therapeutics S.A.

Start price
Target price
Perf. (%)
€1.56
10.09.21
€2.00
10.09.22
-82.43%
02.06.22

Could be worthwhile Investment >10% per year
buy
Catalyst Biosciences Inc

Start price
Target price
Perf. (%)
€2.07
10.09.21
€3.50
31.12.23
-91.67%
08.05.23

Could be very worthwhile Investment >20% year
buy
MacroGenics Inc.

Start price
Target price
Perf. (%)
€19.47
09.09.21
€25.00
31.12.23
-67.12%
08.05.23

Could be very worthwhile Investment >20% year
PerkinElmer Inc.

Start price
Target price
Perf. (%)
€160.00
09.09.21
-
09.09.22
-2.97%
10.03.22

Growths faster than the competition
Could be worthwhile Investment >10% per year
EBIT growth >5% per year expected
buy
QIAGEN NV

Start price
Target price
Perf. (%)
€47.17
09.09.21
-
09.09.22
-13.08%
13.03.22

buy
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€7.15
09.09.21
€10.00
31.12.23
-75.78%
08.05.23

Could be very worthwhile Investment >20% year
buy
Forte Biosciences Inc.

Start price
Target price
Perf. (%)
€3.44
08.09.21
-
08.09.22
-34.88%
08.12.21

Could be worthwhile Investment >10% per year
MacroGenics Inc.

Start price
Target price
Perf. (%)
€17.00
07.09.21
€15.00
31.12.23
14.50%
09.09.21

Could be very worthwhile Investment >20% year
buy
Novo Nordisk A/S ADR

Start price
Target price
Perf. (%)
€85.80
07.09.21
€110.00
31.12.23
24.13%
28.06.22

Could be very worthwhile Investment >20% year
buy
Thermo Fisher Scientific Inc.

Start price
Target price
Perf. (%)
€476.00
07.09.21
€550.00
31.12.23
4.08%
08.05.23

Could be very worthwhile Investment >20% year
buy
Ziopharm Oncology

Start price
Target price
Perf. (%)
€1.99
07.09.21
€4.00
31.12.23
52.84%
01.09.22

Could be worthwhile Investment >10% per year
Poxel S.A.

Start price
Target price
Perf. (%)
€6.46
06.09.21
€5.00
06.09.22
-9.30%
07.10.21

Could be worthwhile Investment >10% per year
buy
Apellis Pharmaceuticals

Start price
Target price
Perf. (%)
€55.00
06.09.21
€120.00
31.12.23
-43.27%
10.09.21

Could be very worthwhile Investment >20% year
buy
ShockWave Medical Inc

Start price
Target price
Perf. (%)
€200.00
06.09.21
€300.00
31.12.23
49.10%
01.09.22

Could be very worthwhile Investment >20% year
buy
Editas Medicine Inc

Start price
Target price
Perf. (%)
€58.60
05.09.21
€70.00
05.09.22
-8.43%
18.09.21

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
Good rating
Very low/no dividend yield expected
buy
Novavax Inc.

Start price
Target price
Perf. (%)
€212.55
05.09.21
€333.00
05.09.22
-85.70%
06.09.22

Top 10 in its market
Could be worthwhile Investment >10% per year
Leading role in innovation
Very Future proof/growth oriented business model
buy
Quoin Pharmaceuticals Ltd. ADR

Start price
Target price
Perf. (%)
€275.00
05.09.21
-
05.09.22
-98.89%
03.09.22

Risky Investment
buy
Innate Pharma

Start price
Target price
Perf. (%)
€4.80
05.09.21
-
05.09.22
-47.79%
07.03.22

Probably not worthwhile Investment
buy
Evotec SE

Start price
Target price
Perf. (%)
€41.53
04.09.21
€45.00
04.09.22
-38.00%
21.05.22

Could be worthwhile Investment >10% per year
Standard Investments for future growth
Innovative
Some uniques
Forte Biosciences Inc.

Start price
Target price
Perf. (%)
€4.42
04.09.21
€2.00
04.09.22
-33.48%
18.09.21

Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Low dividend yield expected
Innate Pharma

Start price
Target price
Perf. (%)
€6.20
03.09.21
-
03.09.22
-25.29%
06.09.21

Risky Investment
buy
Valneva SE

Start price
Target price
Perf. (%)
€20.18
03.09.21
€30.00
03.09.22
-59.38%
03.09.22

Could be worthwhile Investment >10% per year
Future proof or reliable business model
Some uniques
Higher risks for its business